Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125655743 | 12565574 | 3 | F | 20160607 | 20160720 | 20160718 | 20160729 | EXP | US-UNITED THERAPEUTICS-UNT-2016-010101 | UNITED THERAPEUTICS | 43.66 | YR | M | Y | 141.50000 | KG | 20160729 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125655743 | 12565574 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.02 ?G/KG, CONTINUING | Y | 31320112B | 21272 | .02 | UG/KG | INJECTION | |||||
| 125655743 | 12565574 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | UNK | Y | 2100955 | 21272 | INJECTION | ||||||||
| 125655743 | 12565574 | 3 | C | DILTIAZEM. | DILTIAZEM | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 4 | C | REVATIO | SILDENAFIL CITRATE | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 5 | C | COLCRYS | COLCHICINE | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 7 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 8 | C | XARELTO | RIVAROXABAN | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 10 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125655743 | 12565574 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125655743 | 12565574 | 1 | Pulmonary arterial hypertension |
| 125655743 | 12565574 | 3 | Product used for unknown indication |
| 125655743 | 12565574 | 4 | Product used for unknown indication |
| 125655743 | 12565574 | 5 | Product used for unknown indication |
| 125655743 | 12565574 | 6 | Product used for unknown indication |
| 125655743 | 12565574 | 7 | Product used for unknown indication |
| 125655743 | 12565574 | 8 | Product used for unknown indication |
| 125655743 | 12565574 | 9 | Product used for unknown indication |
| 125655743 | 12565574 | 10 | Product used for unknown indication |
| 125655743 | 12565574 | 11 | Product used for unknown indication |
| 125655743 | 12565574 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125655743 | 12565574 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125655743 | 12565574 | Device dislocation | |
| 125655743 | 12565574 | Device related infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125655743 | 12565574 | 1 | 20150916 | 0 |